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Abstract
Background/Aims: High phosphate (Pi) levels and extracellular matrix (ECM) accumulation 
are associated with chronic kidney disease progression. However, how high Pi levels contribute 
to ECM accumulation in mesangial cells is unknown. The present study investigated the role 
and mechanism of high Pi levels in ECM accumulation in immortalized human mesangial cells 
(iHMCs). Methods: iHMCs were exposed to normal (0.9 mM) or increasing Pi concentrations 
(2.5 and 5 mM) with or without diferent blockers or activators. NOX4, phosphorylated 
AMPK (p-AMPK), phosphorylated SMAD3 (p-SMAD3), fibronectin (F/N), collagen IV (C-
IV) and alpha-smooth muscle actin (α-SMA) expression was assessed via western blot and 
immunofluorescence. Lucigenin-enhanced chemiluminescence, and dihydroethidium (DHE) 
assessed NADPH oxidase activity and superoxide (SO), respectively. Results: In iHMCs, a Pi 
transporter blocker (PFA) abrogated high Pi-induced AMPK inactivation, increase in NADPH 
oxidase-induced reactive oxygen species (ROS) levels, NOX4, p-SMAD3, α-SMA and C-IV 
expression. AMPK activation by AICAR, NOX4 silencing or NADPH oxidase blocker prevented 
high Pi-induced DHE levels, p-SMAD3, F/N, C-IV and α-SMA expression. Conclusion: AMPK 
inactivation with NOX4-induced ROS formation and transforming growth factor ß-1 (TGFß-
1) signaling activation mediates high Pi-induced ECM accumulation in iHMCs. Maneuvers 
increasing AMPK or reducing NOX4 activity may contribute to renal protection under 
hyperphosphatemia.
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IntroductionClinical and experimental data indicate that elevated plasma phosphate (Pi) may contribute to progression of chronic kidney disease (CKD) [1–5] by a not fully elucidated mechanism. In spite of that, the effect of high Pi levels per se on kidney cells may play a role, since it has been shown that addition of higher Pi concentrations to the culture 
medium of kidney fibroblasts elicits increased extracellular matrix (ECM) production [6]. 
ECM accumulation in the glomeruli and tubulointerstitial area are well recognized factors 
in the development of glomerulosclerosis and interstitial fibrosis, both anatomical markers of renal disease progression [7, 8]. Glomerular mesangial cells exposed to stimuli that are known to contribute to renal disease progression, such as high glucose, angiotensin II, and 
transforming growth factor (TGFß)-1, produce increased amounts of ECM [9–11]. Whether 
high Pi promotes ECM accumulation in mesangial cells has not yet been investigated.As a serine/threonine kinase, 5' adenosine monophosphate-activated protein kinase 
(AMPK) is an important metabolic sensor expressed ubiquitously in almost all eukaryotic cells 
[12]. The activity and subunit composition of AMPK are expressed in a cell- and tissue-specific manner, with the α1- and α2-subunits expressed in the kidney and in glomerular mesangial 
cells [13]. The activation of AMPK requires the phosphorylation of a critical threonine residue (Thr172) in the activation loop of the α-subunit [14]. It has been previously established that 
AMPK is involved in regulating many cellular functions, including endothelial nitric oxide 
synthase activation, angiogenesis, and mitochondrial function [15]. Further, AMPK may also 
be involved in the pathogenesis of kidney fibrosis [16]. To this end, it has been demonstrated 
that AMPK activation by AICAR prevents renal fibrosis in the rat model of renal ablation [17], 
and also in experimental diabetic nephropathy [18, 19]. We have recently demonstrated that 
human mesangial cells exposed to high glucose concentrations display ECM accumulation 
mediated by reduction in AMPK followed by an activation of NOX4 and TGFß-1 [11]. Also, 
oxidative stress, induced by NOX4 activation, contributes to ECM accumulation, which has 
been demonstrated in mesangial cells treated with angiotensin II or high glucose levels [9, 
10, 20]. The effect of high phosphate levels on AMPK, NOX4, and TGF beta in mesangial cells has not been investigated. The aim of the present study was to investigate whether human mesangial cells exposed 
to high Pi concentrations display increased ECM accumulation mediated by AMPK/NOX4/TGFß-1 signaling.
Materials and Methods 
Reagents
All reagents were purchased from Sigma (St. Louis, MO) unless otherwise stated.
Immortalized human mesangial cell (iHMC) culture
Dr. Nestor Schor (Department of Medicine, Nephrology Division, Federal University of São Paulo, 
Brazil) kindly provided the iHMCs. They were originally from Dr. Bernhard Banas (Nephrology Center, 
Medical Policlinic, Ludwig-Maximilian University of Munich, Germany) and were cultured as described in previous studies [21, 22]. The concentrations of treatments used in high Pi (2.5 and 5 mM) medium in all 
experiments were chosen after carrying out a thiazolyl blue tetrazolium bromide (MTT) assay (data not shown). 
Experimental conditions of iHMCs
The iHMCs were kept for 24 h without serum in Dulbecco´s modified Eagle´s medium (DMEM) 
supplemented with 10% fetal calf serum (Life Technologies, Grand Island, NY) containing 0.9 mM Pi (control) 
or appropriate increasing amounts of sodium phosphate buffer (1 M Na2HPO4/NaH2PO4, pH 7.4) to achieve 
final Pi concentrations of 2.5 and 5 mM. The iHMCs were also treated with 2.5 and 5 mM Pi in the presence 
of phosphonoformic acid (PFA, 1 mM) as a specific inhibitor of the sodium-phosphate transporter that 
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blocks phosphate transport into the cells, or in diphenyleneiodonium as an NADPH oxidase blocker (DPI, 50 
nM), or in small interfering RNA (siRNA) or scramble (Src) for NOX4 (200 nM), or in 5-aminoimidazole-4-
carboxamide ribonucleotide (AICAR, 1 mM) as an activator of AMPK or in mannitol ( 30 mM) as an osmotic control. 
Transient transfection with siRNAs
The siRNA duplexes and scrambled siRNA corresponding to human NOX4 were obtained from 
Invitrogen (Carlsbad, CA). The transient transfection of siRNAs was carried out using lipofectamine 
transfection reagent (Invitrogen, Carlsbad, CA). The siRNA and scrambled (200 nM) for human NOX4 (Invitrogen, Carlsbad, CA) were formulated with lipofectamine transfection reagent according to the manufacturer's instructions after incubation for 24 h in the absence of serum and antibiotics [20].
NADPH oxidase activity
The NADPH oxidase activity was measured by the lucigenin-enhanced chemiluminescence method [23].
Dihydroethidium (DHE) measurement of superoxide production
Superoxide (SO) production was indicated with DHE. Qualitative assessement of SO was carried out 
in the iHMCs after they were kept for 24 h with 0.9, 2.5 or 5 mM Pi in the presence of AICAR, followed 
by incubation with 10 µM DHE fluorescent probes at 37oC for 30 min. Images were then taken with an 
Olympus FluoView fluorescent microscope (Olympus Corporation of the Americas, Melvile, NY). To quantify 
SO levels, the same procedure used for the qualitative analysis of SO was applied. Relative fluorescence was 
measured using a fluorescence plate reader (SynergyMx; Biotek) at excitation and emission wavelengths 
of 520 and 610 nm, respectively. The relative fluorescence values were corrected by the number of cells in each treatment.
Fig. 1. High phosphate le-vels by sodium-phosphate 
transporter increase ECM ac-cumulation via activation of 
TGFß-1 signaling. Represen-tative western blot analysis of 
collagen IV (a), alpha-smooth muscle actin (α-SMA) (c) and 
phosphorylated SMAD3 (e) 
expression in iHMCs under 
0.9 mM or 2.5 mM or 5 mM phosphate alone or in com-
bination with PFA (1 mM) 
followed by quantification of 
collagen IV/actin (b), α-SMA/
actin (d) and pSMAD3/TS-
MAD3/actin (f) ratios. The 
bars represent mean ± SEM of band intensities (arbitrary densitometric units) of 3 in-dependent experiments and n = 5 for each treatment. *p = 
0.01 and #p < 0.0001 vs. 0.9 
mM phosphate for (b). *p < 
0.0001 vs. 0.9 mM phosphate for (d). *p = 0.012 and #p < 
0.0001 vs. 0.9 mM phosphate for (f). 
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Western blot analysis
The samples and Western blots were prepared as described in previous studies [23–25]. The following 
primary antibodies were used: goat anti-type IV collagen (1:500, Southern Biotech, Birmingham, AL), 
goat anti-fibronectin (F/N) (1:500, EMD Millipore, Billerica, MA),  rabbit anti-NOX4 (1:500, Santa Cruz 
Biotechnology, Danvers, MA), rabbit anti-alpha smooth muscle actin (α-SMA) (1:500, Abcam, Cambridge, 
MA), rabbit phosphorylated AMPK (Thr172) and LKB1 (Ser428) (1:1000, Cell Signalling Technology, Danvers, 
MA), rabbit total AMPK and LKB1 (1:1000, Cell Signalling Technology), rabbit phosphorylated SMAD3 
(1:500, Cell Signalling Technology, Danvers, MA), and total rabbit SMAD3 (1:1000, Cell Signalling Technology, 
Danvers, MA). To verify the uniformity of the protein load and transfer efficiency across the test samples, 
the membranes were reprobed with actin (goat polyclonal anti-actin antibody, diluted 1:1000; Santa Cruz 
Biotechnology, Danvers, MA). 
Immunofluorescence for α-SMA 
Immunofluorescence staining was performed by incubating fixed iHMCs in 4 % paraformaldehyde with α-SMA primary antibody (1:10; Abcam) and rhodamine-conjugated secondary antibody (1:500, BD 
Fig. 2. High phosphate 
levels inactivate AMPK 
and increase NADPH oxidase activity and 
NOX4 expression by s o d i u m - p h o s p h a t e 
transporter in iHMCs. 
Representative wes-tern blot analysis of 
phosphorylated AMPK 
(pAMPK) (Thr172) (a) 
expression in iHMCs 
under 0.9 mM or 2.5 
mM or 5 mM phosphate alone or in combination 
with PFA (1 mM) follo-
wed by quantification 
of pAMPK/TAMPK/ac-tin (b), ratio. The bars 
represent mean ± SEM of band intensities (ar-bitrary densitometric units) of 3 independent experiments and n = 5 for each treatment. *p = 0.02 and #p < 0.0001 
vs. 0.9 mM phosphate. 
(c). NADPH-dependent 
ROS generation in iH-
MCs in conditions as in-dicated, and expressed as a percentage of rela-
tive luminescence units (RLU)/µg protein. The bars represent mean ± SD of 3 independent experiments and 
n = 6 for each treatment. *p = 0.01 and #p < 0.0001 vs. 0.9 mM phosphate. (d). Representative western blot 
analysis of NOX4 expression in iHMCs in conditions as indicated followed by quantification of NOX4/actin 
(e) ratio. The bars represent mean ± SEM of band intensities (arbitrary densitometric units) of 3 indepen-
dent experiments and n = 5 for each treatment. *p = 0.02 and #p < 0.0001 vs. 0.9 mM phosphate. 
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Transduction Labs, San Jose, CA). Images were then taken and analyzed by Confocal Microscopy (Leica TCS 
SP5 II), 40x of magnification.
Statistical analysis
Results are expressed as mean ± standard error of mean (SEM), and comparisons between multiple 
groups are performed with one-way analysis of variance (ANOVA) followed by the Bonferroni test, while a 
t-test was used for comparisons between two groups. Analyses are considered significant at p < 0.05. The 
analyses were performed using StatView software (SAS Institute Inc., Cary, NC).
Results 
High phosphate levels increased ECM accumulation associated with elevated TGFß-1 
signaling
The expression levels of both collagen IV, α-SMA, and phosphorylated SMAD3 were 
significantly elevated in iHMCs exposed to high Pi levels (Fig. 1a-f) and they were both prevented after PFA treatment. 
Signaling pathways induced by phosphate in mesangial cells
High phosphate levels induced oxidative stress by NADPH oxidase activation via NOX4 
following inactivation of AMPK. The expression levels of phosphorylated AMPK were 
significantly reduced (Fig. 2a and b), and ROS formation via NADPH oxidase (Fig. 2c), and 
NOX4 expression (Fig. 2d and e) increased in a concentration-dependent manner in iHMCs exposed to high Pi levels, and these were reversed by PFA treatment. Treatment of mesangial 
cells with AICAR, an AMPK activator (Fig. 3a-d), prevented the increment in NOX4 expression 
Fig. 3. AICAR pre-vents high phospha-
te-induced AMPK in-
activation in iHMCs. 
Representative wes-tern blot analysis of 
phosphorylated AMPK 
(pAMPK) (Thr172) (a 
and c) in iHMCs un-
der 0.9 mM phospha-
te or 2.5 mM or 5 mM phosphate alone or in combination with AI-
CAR (1 mM) followed 
by quantification of 
pAMPK/TAMPK/actin ratio (b and d). The bars represent mean 
± SEM of band inten-sities (arbitrary den-sitometric units) of 3 independent experi-ments and n = 5 for each treatment. **p = 
0.01 vs. 0.9 mM phos-phate for (a). *p = 0.04 
vs. 0.9 mM phosphate for (b). 
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(Fig. 4a and b), NADPH oxidase activity (Fig. 4c), SO production (Fig. 5a-b), phosphorylated 
SMAD3 (Fig. 6a and b), collagen IV (Fig. 6c and d), fibronectin (Fig. 6e and f) and α-SMA (Fig. 
Fig. 4. High phosphate levels in-
crease NADPH oxidase activation 
and particularly NOX4 expres-
sion via AMPK inactivation in 
iHMCs. Representative western 
blot analysis of NOX4 (a) in iH-
MCs under 0.9 mM or 2.5 mM 
or 5 mM phosphate alone or in 
combination with AICAR (1 mM) 
followed by quantification of 
NOX4/actin (b) ratio. The bars 
represent mean ± SEM of band intensities (arbitrary densito-metric units) of 3 independent experiments. *p = 0.035 and #p 
< 0.0001 vs. 0.9 mM phosphate. 
(c). NADPH-dependent ROS ge-
neration in iHMCs in conditions as indicated and expressed as percentage of relative lumine-
scence units (RLU)/µg protein. The bars represent mean ± SD of 3 independent experiments and n = 5 for each treatment. *p = 
0.01 and #p < 0.0001 vs. 0.9 mM phosphate. 
Fig. 5. High phosphate levels in-
crease SO production via AMPK 
inactivation in iHMCs. Qualitative 
assessment of SO formation (a). 
SO levels were assessed by incu-
bating iHMCs with 10 µM DHE for 30 min. Images were then taken 
under fluorescent microscope and colored images are illustra-
ting SO signal for each treatment 
(a). Quantitative assessment of 
SO formation via fluorometric measurement (b). The bars repre-
sent mean±SEM of 3 independent experiments and values are ex-
pressed as percentage of fluores-
cence units. *p < 0.001 vs. 0.9 mM phosphate. 
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7a-c) expressions induced by high Pi levels. Inactivation of AMPK by high Pi levels may occur due to reduction of phosphorylated liver kinase B1 (LKB1), a critical upstream activator of 
AMPK (Fig. 8a and b). 
Activation of NADPH oxidase and particularly NOX4 by high phosphate levels increases 
TGFß-1 signaling and ECM accumulation. Pharmacological blockade of NADPH oxidase 
with DPI (Fig. 9a-d) or NOX4 silencing (Fig. 10a-d) abrogated high Pi-induced increase in 
phosphorylated SMAD3 (Fig. 9a-b and Fig. 10e-f), collagen IV (Fig. 9c-d and Fig. 11a-b) and 
fibronectin (Fig. 11c-d) expression. 
Discussion Thus far, the cellular mechanism by which hyperphosphatemia is involved in renal disease progression has not been assessed in great detail. In the current study, we showed, 
for the first time, that in human mesangial cells, elevated Pi medium concentrations via the 
sodium-phosphate transporter lead to an increase in the pro-fibrotic proteins, collagen IV 
and fibronectin. Elevated Pi also activates mesangial as showed by increased α-SAM actin 
expression. High Pi levels inactivate AMPK, leading to the upregulation of NOX4 expression 
and subsequent activation of TGFß-1 signaling via phosphorylation of SMAD3 that ultimately 
leads to increased collagen IV, fibronectin and α-SMA levels (Fig. 12).
Fig. 6. High phosphate levels increase TGFß-1 
signaling and ECM accu-
mulation following AMPK 
inactivation in iHMCs. Re-presentative western blot analysis of phosphoryla-
ted SMAD3 (a), collagen 
IV (c) and fibronectin 
(e) expression in iHMCs 
under 0.9 mM or 2.5 
mM or 5 mM phosphate alone or in combination 
with AICAR (1 mM) fol-
lowed by quantification 
of pSMAD3/TSMAD3/
actin (b), collagen IV/ac-
tin (d) and fibronectin/actin (f) ratios. The bars 
represent mean ± SEM of band intensities (arbitra-ry densitometric units) of 3 independent experi-ments and n = 5 for each treatment. *p = 0.03 and 
#p < 0.0001 vs. 0.9 mM phosphate for (b). *p = 0.01 and #p < 0.0001 vs. 
0.9 mM phosphate for 
(d). . *p < 0.0001 vs. 0.9 
mM phosphate for (f).
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Fig. 7. High phosphate levels increase alpha-smooth muscle actin (α-SMA) following AMPK 
inactivation in iHMCs. 
Representative western blot analysis of α-SMA 
expression (a) in iHMCs 
under 0.9 mM or 2.5 
mM or 5 mM phosphate alone or in combination 
with AICAR (1 mM) fol-
lowed by quantification of α-SMA/actin ratio (b). The bars represent mean 
± SEM of band intensities (arbitrary densitometric units) of 3 independent experiments and n = 5 for each treatment. *p < 
0.0001 vs. 0.9 mM phos-
phate (c). Immunoflu-orescence staining for alpha-smooth muscle actin (α-SMA) in iHMCs treated as indicated. 
TOPRO marker shows nuclear staining. Images 
were analyzed by Con-
focal Microscopy, 40x of 
magnification.
Fig. 8. High phosphate levels inactivate LKB1 in iH-
MCs. Representative western blot analysis of phos-phorylated LKB1 (pLKB1) (Ser428) (a) in iHMCs un-
der 0.9 mM or 2.5 mM or 5 mM phosphate followed 
by quantification of pLKB1/TLKB1/actin ratio (b). 
The bars represent mean ± SEM of band intensities (arbitrary densitometric units) of 3 independent ex-periments and n = 5 for each treatment. *p < 0.001 
vs. 0.9 mM phosphate. 
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Glomerular ECM accumulation with subsequent development of glomerulosclerosis is 
associated with progression of CKD [7]. Maneuvers aimed at reduction in plasma Pi levels 
are associated with reduction of glomerulosclerosis and interstitial fibrosis in uremic rats [4]. In the current study, the medium concentrations used in mesangial cells are comparable to a 2- to 4-fold increase of serum Pi concentrations, which indicate that even mild increases 
in serum Pi concentrations in vivo may have a critical stimulatory role on fibrogenesis in the kidney.
Our results identify, for the first time, that NOX4 is an upstream critical activator in 
mediating ECM accumulation via rise in TGFß-1 signaling in mesangial cells exposed to elevated levels of Pi, and this is in agreement with our previous study of mesangial cells 
exposed to diabetic conditions [11]. The upregulation of NOX4 has been linked with a rise in 
fibronectin [9, 10, 26] in mesangial and tubular cells exposed, for example, to high glucose, as well as with an increase in mesangial hypertrophy under angiotensin II treatment [27, 28]. 
The importance of targeting NOX4 activation as a renoprotective maneuver has been clearly 
demonstrated in an experimental model of diabetic nephropathy [29].
The inactivation of AMPK has been known to contribute to ECM accumulation and 
kidney hypertrophy [19, 30, 31] and, more importantly, to kidney fibrosis [16]. Use of AICAR, 
which activates AMPK, in a model of CDK in rats led to a reduction in kidney fibrosis [17]. 
Our previous study [11] showed, for the first time, that the inactivation of AMPK upstream of 
NOX4 is a critical step in regulating both high glucose and TGFß-1-induced ECM accumulation. 
Our current study extends our previous findings by demonstrating that AMPK/NOX4/TGFß-
1 signaling also mediates high Pi-induced profibrotic damage in mesangial cells. 
In conclusion, this study has identified AMPK and NOX4 as critical players in the cellular 
mechanism for high Pi-induced ECM accumulation via TGFß-1 signaling in human mesangial 
cells. The efficacy of maneuvers to increase AMPK and reduce NOX4 activity aiming to confer renal protection in vivo under hyperphosphatemia deserves further investigation. 
Fig. 9. High phosphate levels increase TGFß-1 si-
gnaling and ECM accumu-
lation via NADPH oxidase 
activation in iHMCs. Re-presentative western blot analysis of phosphorylated 
SMAD3 (a) and collagen 
IV expression (c) in iHMCs 
under 0.9 mM or 2.5 mM 
or 5 mM phosphate alone or in combination with DPI 
(50 nM) followed by quan-
tification of pSMAD3/TS-
MAD3/actin ratio (b) and 
collagen IV/actin ratios (d). The bars represent mean 
± SEM of band intensities (arbitrary densitometric units) of 3 independent experiments and n = 5 for each treatment. *p = 0.015 
and #p < 0.0001 vs. 0.9 mM phosphate for (b). *p = 0.02 
and #p < 0.0001 vs. 0.9 
mM phosphate vs. 0.9 mM phosphate for (d).
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Fig. 10. High phosphate levels increase TGFß-1 sig-
naling via increase in NOX4 
expression in iHMCs. Repre-sentative western blot ana-
lysis of NOX4 (a and c), and 
phosphorylated SMAD3 (e) 
expression in iHMCs under 
0.9 mM or 2.5 mM or 5 mM phosphate alone or in com-bination with transfection of 
scramble NOX4 plasmid (src 
200 nM) or with transfection 
of siRNA NOX4 plasmid (si, 
200 nM) followed by quanti-
fication of NOX4/actin ratio 
(b and d), and pSMAD3/TS-
MAD3/actin (f) ratios. The 
bars represent mean ± SEM of band intensities (arbitrary densitometric units) of 3 in-dependent experiments and n = 5 for each treatment. *p 
= 0.001 vs. 0.9 mM phospha-te for (b). *p = 0.02 and #p < 
0.0001 vs. 0.9 mM phosphate for (d). *p = 0.002 and #p < 
0.0001 vs. 0.9 mM phosphate for (f). 
Fig. 11. High phosphate 
levels increase ECM ac-cumulation via increase 
in NOX4 expression in 
iHMCs. Representative western blot analysis of 
collagen IV (a), and fib-ronectin (c) expression 
in iHMCs treated as indi-
cated followed by quan-
tification of collagen IV/
actin (b), and fibronec-tin/actin (d) ratios. The bars represent mean ± 
SEM of band intensities (arbitrary densitometric units) of 3 independent experiments and n = 5 for each treatment. *p = 0.01 
and #p < 0.0001 vs. 0.9 
mM phosphate for (b). *p = 0.0002 and #p < 0.0001 
vs. 0.9 mM phosphate for (d).
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